These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4750562)

  • 1. Dependence of anticonvulsant drug action on central monoamines.
    Meyer H; Frey HH
    Neuropharmacology; 1973 Oct; 12(10):939-47. PubMed ID: 4750562
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 3. Central monoamines and convulsine thresholds in mice and rats.
    Kilian M; Frey HH
    Neuropharmacology; 1973 Jul; 12(7):681-92. PubMed ID: 4730377
    [No Abstract]   [Full Text] [Related]  

  • 4. Convulsive thresholds and the activity of anticonvulsants in electroseizure test. The role of serotoninergic system.
    Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(2):143-55. PubMed ID: 934946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the anticonvulsant properties of 2-diethylaminopento-4-ynoyl-2',6'-xylidide (WY 21745) with lignocaine, phenytoin, phenobarbitone and trimethadione.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):405-14. PubMed ID: 5559826
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate.
    Piredda SG; Woodhead JH; Swinyard EA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):741-5. PubMed ID: 3919174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic interactions of albutoin with other anticonvulsant drugs.
    Wallin RF; Blackburn WH; Napoli MD
    J Pharmacol Exp Ther; 1970 Aug; 174(2):276-82. PubMed ID: 5451364
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between morphine-like analgesics and anticonvulsant drugs.
    Frey HH
    Pharmacol Toxicol; 1987 Mar; 60(3):210-3. PubMed ID: 2884653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of mice to seizures after some anticonvulsant drugs.
    Rümke CL
    Eur J Pharmacol; 1967 Sep; 1(5):369-77. PubMed ID: 4385121
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of flunarizine and nifedipine alone and in combination with anticonvulsant drugs against PTZ-induced seizures in mice.
    Rodger C; Pleuvry BJ
    Neuropharmacology; 1993 Mar; 32(3):257-63. PubMed ID: 8474621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant properties of cannabidiol.
    Turkanis SA; Cely W; Olsen DM; Karler R
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):231-46. PubMed ID: 4850602
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticonvulsant activities of delta-8 and delta-9 tetrahydrocannabinol and uridine.
    Dwivedi C; Harbison RD
    Toxicol Appl Pharmacol; 1975 Mar; 31(3):452-8. PubMed ID: 1145630
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D
    Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
    Consroe P; Martin P; Eisenstein D
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):1-13. PubMed ID: 841172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTE ON THE INTERACTIONS OF AMPHETAMINE WITH ANTICONVULSANT DRUGS.
    FREY HH
    Acta Pharmacol Toxicol (Copenh); 1964; 21():290-8. PubMed ID: 14209620
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic interactions of phenytoin in the rat: effect of coadministration with the anticonvulsant drugs sodium valproate, sulthiame, ethosuximide or phenobarbital.
    Patsalos PN; Lascelles PT
    Gen Pharmacol; 1984; 15(1):7-12. PubMed ID: 6141984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of seizures and anticonvulsant agents on hippocampal RNA concentration.
    Tannhauser M; Izquierdo I
    Pharmacology; 1974; 11(3):139-45. PubMed ID: 4831802
    [No Abstract]   [Full Text] [Related]  

  • 18. Thresholds for electro- and chemoconvulsions in mice after termination of treatment with phenobarbital.
    Kilian M; Frey HH
    Pharmacology; 1973; 10(3):169-77. PubMed ID: 4761779
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological and biochemical studies on 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004): a new sulphonamide with anticonvulsant and carbonic anhydrase inhibitory properties.
    Lassen JB; Christensen JA; Lund J; Squires RF
    Acta Pharmacol Toxicol (Copenh); 1971; 30(1):1-16. PubMed ID: 5171350
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of repeated flurothyl-induced seizures on convulsive thresholds and brain monoamines in rats.
    Adler MW; Sagel S; Kitagawa S; Segawa T; Maynert EW
    Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):12-21. PubMed ID: 4383498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.